MNKD EBITDA | MANNKIND CORP

MANNKIND CORP (MNKD) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$350.00K; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.67M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $18.90M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $5.30M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2010-12-31 to 2017-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$350.00K	(m)	$109.37M	(m)	$5.08M*	-$18.37M*	$14.41M	(m)	$58.30M	-$106.00K
2026-03-31	Reported	(m)	-$1.67M	(m)	$90.17M	(m)	$1.88M	-$5.37M	$7.51M	(m)	$54.09M	$253.00K
2025-09-30	Reported	(m)	$18.90M	(m)	$82.13M	(m)	$1.13M*	$23.64M*	$4.50M	(m)	$29.09M	-$204.00K
2025-06-30	Reported	(m)	$5.30M	(m)	$76.53M	(m)	$1.12M*	$8.95M*	$4.61M	(m)	$31.62M	$272.00K
2025-03-31	Reported	(m)	$22.29M	(m)	$78.35M	(m)	$330.00K	-$6.38M	$3.77M	(m)	$25.01M	$459.00K
2024-09-30	Reported	(m)	$12.76M	(m)	$70.08M	(m)	$1.42M*	$9.33M*	$3.20M	(m)	$23.92M	$1.32M
2024-06-30	Reported	(m)	$16.61M	(m)	$72.39M	(m)	$2.97M*	$3.83M*	$5.61M	(m)	$24.11M	$323.00K
2024-03-31	Reported	(m)	$16.72M	(m)	$66.26M	(m)	$2.41M	$6.70M	$3.82M	(m)	$22.33M	$264.00K
2023-09-30	Reported	(m)	$5.10M	(m)	$51.25M	(m)	$11.39M*	$8.66M*	$4.00M	(m)	(m)	$0.00
2023-06-30	Reported	(m)	$1.72M	(m)	$48.61M	(m)	$16.87M*	$2.60M*	$5.22M	(m)	(m)	$0.00
2023-03-31	Reported	(m)	-$6.00M	(m)	$40.63M	(m)	$8.31M	$1.16M	$5.53M	(m)	(m)	$0.00
2022-09-30	Reported	(m)	-$9.61M	(m)	$32.83M	(m)	$271.00K*	-$28.07M*	$5.02M	(m)	$22.64M	$0.00
2022-06-30	Reported	(m)	-$20.45M	(m)	$18.89M	(m)	-$2.83M*	-$31.98M*	$4.62M	(m)	$26.04M	$0.00
2022-03-31	Reported	(m)	-$21.26M	(m)	$11.99M	(m)	$5.06M	-$18.25M	$2.28M	(m)	$20.70M	$0.00
2021-09-30	Reported	(m)	-$6.59M	(m)	$22.21M	(m)	$4.25M*	-$15.18M*	$3.81M	(m)	$17.22M	(m)
2021-06-30	Reported	(m)	-$10.27M	(m)	$23.28M	(m)	$1.05M*	-$21.45M*	$4.41M	(m)	$20.06M	(m)
2021-03-31	Reported	(m)	-$6.19M	(m)	$17.44M	(m)	$976.00K	-$12.73M	$4.32M	(m)	$17.41M	(m)
2020-09-30	Reported	(m)	-$9.13M	(m)	$15.35M	(m)	$4.00K*	-$13.46M*	$3.59M	(m)	$13.90M	-$218.00K
2020-06-30	Reported	(m)	-$7.92M	(m)	$15.11M	(m)	$150.00K*	-$3.68M*	$3.68M	(m)	$13.67M	(m)
2020-03-31	Reported	(m)	-$7.12M	(m)	$16.23M	(m)	$150.00K	-$11.22M	$4.16M	(m)	$14.35M	(m)
2019-09-30	Reported	(m)	-$8.78M	(m)	$14.60M	(m)	$963.00K*	-$52.05M*	$7.10M	(m)	$16.67M	$0.00
2019-06-30	Reported	(m)	-$10.95M	(m)	$15.00M	(m)	$1.22M*	-$19.73M*	$4.33M	(m)	$16.61M	(m)
2019-03-31	Reported	(m)	-$13.51M	(m)	$17.45M	(m)	$269.00K	-$11.60M	$4.02M	(m)	$25.67M	(m)
2018-09-30	Reported	(m)	-$21.54M	(m)	$4.47M	(m)	(m)	-$13.92M*	$5.30M	(m)	$19.39M	$0.00*
2018-06-30	Reported	(m)	-$20.54M	(m)	$3.89M	(m)	(m)	-$27.15M*	$5.09M	(m)	$21.73M	$240.00K
2018-03-31	Reported	(m)	-$26.79M	(m)	$3.46M	(m)	(m)	-$21.65M	$4.01M	(m)	$20.62M	$0.00
2017-09-30	Reported	(m)	-$28.18M	(m)	$2.04M	(m)	(m)	-$23.27M*	$4.58M	(m)	$17.73M	$0.00
2017-06-30	Reported	(m)	-$31.57M	(m)	$2.16M	(m)	(m)	(m)	$5.09M	(m)	$18.57M	$0.00
2017-03-31	Reported	-$19.2M	(m)	(m)	(m)	-638.15%	(m)	(m)	(m)	(m)	$15.39M	$0.00
2016-09-30	Reported	(m)	$118.23M	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)	$13.13M	$0.00
2016-06-30	Reported	-$18.54M	(m)	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)	$11.11M	$0.00
2016-03-31	Reported	-$19.41M	(m)	(m)	(m)	(m)	$1.14M	(m)	(m)	(m)	$7.35M	$0.00
2015-12-31	Reported	-$270.15M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$22.84M	(m)	(m)	(m)	(m)	$1.23M*	(m)	(m)	(m)	$11.55M	$0.00
2015-06-30	Reported	-$21.31M	(m)	(m)	(m)	(m)	$4.53M*	(m)	(m)	(m)	$10.62M	$0.00
2015-03-31	Reported	-$19.44M	(m)	(m)	(m)	(m)	$4.20M	(m)	(m)	(m)	(m)	$0.00
2014-12-31	Reported	-$25.28M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$35.82M	(m)	(m)	(m)	(m)	$9.47M*	(m)	(m)	(m)	(m)	$0.00
2014-06-30	Reported	-$67.4M	(m)	(m)	(m)	(m)	$8.26M*	(m)	(m)	(m)	(m)	$0.00
2014-03-31	Reported	-$38.91M	(m)	(m)	(m)	(m)	$1.41M	(m)	(m)	(m)	(m)	$0.00
2013-12-31	Reported	-$43.94M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$41.89M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Reported	-$38.63M	(m)	(m)	(m)	(m)	$132.00K*	-$29.74M*	(m)	(m)	(m)	(m)
2013-03-31	Reported	-$33.45M	(m)	(m)	(m)	(m)	$1.46M	-$32.03M	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$30.38M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$32.25M	(m)	(m)	(m)	-92142.86%	$124.00K*	-$34.26M*	(m)	(m)	(m)	-$408.00K
2012-06-30	Reported	-$40.75M	(m)	(m)	(m)	(m)	$125.00K*	-$25.02M*	(m)	(m)	(m)	(m)
2012-03-31	Reported	-$30.58M	(m)	(m)	(m)	(m)	$323.00K	-$32.49M	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$27.1M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$29.03M	(m)	(m)	(m)	(m)	$594.00K*	-$36.03M*	(m)	(m)	(m)	(m)
2011-06-30	Reported	-$35.61M	(m)	(m)	(m)	(m)	$4.12M*	-$36.74M*	(m)	(m)	(m)	(m)
2011-03-31	Reported	(m)	-$38.00M	(m)	(m)	(m)	$1.99M	-$30.70M	(m)	(m)	(m)	(m)
2010-09-30	Reported	(m)	-$42.54M	(m)	(m)	(m)	$1.55M*	-$34.85M*	(m)	(m)	(m)	(m)
2010-06-30	Reported	(m)	-$37.26M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$38.80M	(m)	$348.97M	(m)	$4.57M	$18.25M	$26.80M	(m)	$144.13M	-$4.46M
2024-12-31	Reported	(m)	$72.59M	(m)	$285.50M	(m)	$9.69M	$42.51M	$17.43M	(m)	$94.33M	$2.93M
2023-12-31	Reported	(m)	$8.68M	(m)	$198.96M	(m)	$42.44M	$34.09M	$20.86M	(m)	$94.31M	$1.56M
2022-12-31	Reported	(m)	-$64.11M	(m)	$99.77M	(m)	$7.59M	-$80.68M	$16.00M	(m)	$91.47M	$0.00
2021-12-31	Reported	(m)	-$47.02M	(m)	$75.44M	(m)	$11.47M	-$61.71M	$16.83M	(m)	$77.42M	$0.00
2020-12-31	Reported	(m)	-$47.91M	(m)	$65.14M	(m)	$801.00K	-$28.13M	$15.08M	(m)	$59.04M	-$218.00K
2019-12-31	Reported	(m)	-$44.60M	(m)	$63.04M	(m)	$2.56M	-$88.48M	$20.08M	(m)	$74.67M	$0.00
2018-12-31	Reported	(m)	-$76.59M	(m)	$27.86M	(m)	$354.00K	-$37.73M	$19.39M	(m)	$79.72M	$240.00K
2017-12-31	Reported	-$106.39M	(m)	(m)	(m)	-905.82%	(m)	-$64.78M	$17.23M	(m)	$74.96M	$51.00K
2016-12-31	Reported	$69.66M	(m)	(m)	(m)	39.86%	$1.14M	-$78.09M	$17.12M	(m)	$46.93M	$0.00
2015-12-31	Reported	-$333.66M	(m)	(m)	(m)	(m)	$10.29M	(m)	(m)	(m)	$40.96M	$0.00
2014-12-31	Reported	-$169.83M	(m)	(m)	(m)	(m)	$24.10M	(m)	(m)	(m)	$79.38M	$0.00
2013-12-31	Reported	-$157.9M	(m)	(m)	(m)	(m)	$7.99M	-$128.73M	(m)	(m)	(m)	$0.00
2012-12-31	Reported	-$133.96M	(m)	(m)	(m)	-382742.86%	$637.00K	-$119.86M	(m)	(m)	(m)	-$408.00K
2011-12-31	Reported	-$125.94M	(m)	(m)	(m)	-251878.00%	$6.86M	-$123.84M	(m)	(m)	(m)	(m)
2010-12-31	Reported	-$136M	(m)	(m)	(m)	-146234.41%	$9.54M	-$148.65M	(m)	(m)	(m)	(m)
2009-12-31	Reported	(m)	-$209.78M	(m)	(m)	(m)	$18.85M	-$184.08M	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Alto Neuroscience, Inc. (ANRO)	United States	$1.065B	-11.02
Savara Inc (SVRA)	United States	$1.044B	-9.10
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.031B	-5.43
Pacira BioSciences, Inc. (PCRX)	United States	$1.020B	69.03
Janux Therapeutics, Inc. (JANX)	United States	$1.019B	-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)	United States	$1.116B	10.93
Corvus Pharmaceuticals, Inc. (CRVS)	United States	$0.994B	-23.25
Seaport Therapeutics, Inc. (SPTX)	United States	$1.131B
Kura Oncology, Inc. (KURA)	United States	$0.967B	-3.29
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19